Nrf2: The Master and Captain of Beta Cell Fate.
| Citation | Baumel-Alterzon, Sharon, et al. “Nrf2: The Master and Captain of Beta Cell Fate”. 2021. Trends in Endocrinology and Metabolism: TEM, vol. 32, no. 1, 2021, pp. 7–19. |
| Center | Albert Einstein College of Medicine |
| Author | Sharon Baumel-Alterzon, Liora S Katz, Gabriel Brill, Adolfo Garcia-Ocaña, Donald K Scott |
| Keywords | Nrf2, diabetes, Metabolic stress, oxidative stress, pancreatic beta cell, proliferation |
| Abstract |
Prolonged hyperglycemia is toxic to pancreatic β cells, generating excessive reactive oxygen species, defective glucose-stimulated insulin secretion, decreased insulin production, and eventually β cell death and diabetes. Nrf2 is a master regulator of cellular responses to counteract dangerous levels of oxidative stress. Maintenance of β cell mass depends on Nrf2 to promote the survival, function, and proliferation of β cells. Indeed, Nrf2 activation decreases inflammation, increases insulin sensitivity, reduces body weight, and preserves β cell mass. Therefore, numerous pharmacological activators of Nrf2 are being tested in clinical trials for the treatment of diabetes and diabetic complications. Modulating Nrf2 activity in β cells is a promising therapeutic approach for the treatment of diabetes. |
| Year of Publication |
2021
|
| Journal |
Trends in endocrinology and metabolism: TEM
|
| Volume |
32
|
| Issue |
1
|
| Number of Pages |
7-19
|
| Date Published |
01/2021
|
| ISSN Number |
1879-3061
|
| DOI |
10.1016/j.tem.2020.11.002
|
| Alternate Journal |
Trends Endocrinol Metab
|
| PMCID |
PMC7746592
|
| PMID |
33243626
|
| Download citation |